Patent · US Active

Improving vascular function with an inactivating mutant of a TRPC channel protein

US8193150B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

Sanofi · FR

Inventor

Carsten Struebing · Frankfurt, DE

Key dates

Filing date	Aug 25, 2011
Grant date	Jun 5, 2012
Priority date	—
Expiry date	Aug 25, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/323
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers to the use of a TRPC channel, an inactivating mutant thereof, or a nucleotide sequence coding for the TRPC channel or for the inactivating mutant for the production of a medicament for the treatment of a cardiovascular disease and a method of screening a modulator of the TRPC channel or an inactivating mutant thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.